Get the SPI Wire

Champions Oncology, Inc.

NASDAQ:CSBR
Annual Meeting

of Shareholders

MEETING DATE

10/14/2026
DEF 14A FILED
08/28/2026
PUBLISHED
08/28/2026 7:35 pm
TIME TO PUBLISH
08/30/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:CSBR · CUSIP 15870P307 · CLASS common stock · CIK 0000771856

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

5
FOR
0
AGAINST
0
WITHHOLD
5
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The board unanimously approved the seven nominees, and each nominee currently serves as a director.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratification of Appointment of Independent Registered Public Accounting Firm
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The audit committee appointed EisnerAmper LLP for fiscal 2027 and pre-approved all services provided.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Non-Binding Proposal to Approve the Compensation of Our Executive Officers
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states the vote is advisory and the compensation committee will consider the outcome.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
Non-Binding Advisory Vote on Frequency of Holding Stockholder Non-Binding Advisory Votes on Executive Compensation
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The board recommends submitting the advisory vote on executive compensation every three years.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
The 2026 Equity Incentive Plan
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states approval is necessary to meet Nasdaq requirements and grant incentive stock options.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

4332ab61648017c9eb256ec060ad61205d97e6e146cb4d87cdb8db2f41d34f55

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates